Identifier
Created
Classification
Origin
09TOKYO1534
2009-07-06 07:33:00
UNCLASSIFIED
Embassy Tokyo
Cable title:
JAPAN REPORTS FIRST CASE OF TAMIFLU-RESISTANT H1N1
how-toVZCZCXRO6472 OO RUEHAST RUEHDH RUEHHM RUEHLN RUEHMA RUEHPB RUEHPOD RUEHSL RUEHTM RUEHTRO DE RUEHKO #1534 1870733 ZNR UUUUU ZZH O 060733Z JUL 09 FM AMEMBASSY TOKYO TO RUEHC/SECSTATE WASHDC IMMEDIATE 4348 INFO RUEHZN/ENVIRONMENT SCIENCE AND TECHNOLOGY COLLECTIVE RUEHME/AMEMBASSY MEXICO CITY 0640 RUEHUL/AMEMBASSY SEOUL 6319 RUEHBJ/AMEMBASSY BEIJING 0299 RUEHFK/AMCONSUL FUKUOKA 5067 RUEHNAG/AMCONSUL NAGOYA 2583 RUEHNH/AMCONSUL NAHA 7398 RUEHOK/AMCONSUL OSAKA KOBE 8870 RUEHKSO/AMCONSUL SAPPORO 5588 RUEHGV/USMISSION GENEVA 3565 RUCNDT/USMISSION USUN NEW YORK 6000 RHHMUNA/HQ USPACOM HONOLULU HI RUEKJCS/SECDEF WASHINGTON DC RUEHRC/USDA FAS WASHDC 8645 RUEAUSA/DEPT OF HHS WASHINGTON DC RHMFIUU/DEPT OF HOMELAND SECURITY IA WASHINGTON DC RUEAIIA/CIA WASHDC RHMFIUU/USFJ
UNCLAS TOKYO 001534
DEPT FOR OES/IHB AMBASSADOR LOFTIS
DEPT FOR EAP/J, EAP/EX, CA
USDA PASS TO APHIS, FAS FOR BURDETT
HHS PASS TO CDC
HHS FOR OGHA
DEPT PASS TO AID/GH/HIDN
SIPDIS
E.O. 12958: N/A
TAGS: KFLU TBIO JA
SUBJECT: JAPAN REPORTS FIRST CASE OF TAMIFLU-RESISTANT H1N1
INFLUENZA
UNCLAS TOKYO 001534
DEPT FOR OES/IHB AMBASSADOR LOFTIS
DEPT FOR EAP/J, EAP/EX, CA
USDA PASS TO APHIS, FAS FOR BURDETT
HHS PASS TO CDC
HHS FOR OGHA
DEPT PASS TO AID/GH/HIDN
SIPDIS
E.O. 12958: N/A
TAGS: KFLU TBIO JA
SUBJECT: JAPAN REPORTS FIRST CASE OF TAMIFLU-RESISTANT H1N1
INFLUENZA
1. The Ministry of Health, Labor and Welfare (MHLW) announced July
2 it has detected the first case in Japan of Tamiflu-resistant H1N1
influenza A virus. The patient, a woman in her 40s from Toyonaka,
Osaka Prefecture, had been administered Tamiflu since May 18 as a
preventive measure after she was found to have had close contact
with another patient infected with the H1N1 virus. The woman
developed symptoms May 29 and the Osaka Prefectural Institute of
Public Health confirmed June 18 the woman had been infected with a
strain of the H1N1 virus containing a genetic mutation making it
resistant to Tamiflu. The patient recovered after being given the
drug Relenza.
2. In a July 2 press conference, representatives of the Osaka
Prefectural Government explained the lag between detecting the
Tamiflu resistant strain and reporting it to MHLW on July 1 was due
to further tests needed to re-confirm the initial conclusion.
However, three Institute employees had submitted a paper on the
findings to the U.S. medical journal "Emerging Infectious Diseases"
June 24. Japanese media criticized the Institute as giving priority
to academic reports and not releasing information to the domestic
public.
ZUMWALT
DEPT FOR OES/IHB AMBASSADOR LOFTIS
DEPT FOR EAP/J, EAP/EX, CA
USDA PASS TO APHIS, FAS FOR BURDETT
HHS PASS TO CDC
HHS FOR OGHA
DEPT PASS TO AID/GH/HIDN
SIPDIS
E.O. 12958: N/A
TAGS: KFLU TBIO JA
SUBJECT: JAPAN REPORTS FIRST CASE OF TAMIFLU-RESISTANT H1N1
INFLUENZA
1. The Ministry of Health, Labor and Welfare (MHLW) announced July
2 it has detected the first case in Japan of Tamiflu-resistant H1N1
influenza A virus. The patient, a woman in her 40s from Toyonaka,
Osaka Prefecture, had been administered Tamiflu since May 18 as a
preventive measure after she was found to have had close contact
with another patient infected with the H1N1 virus. The woman
developed symptoms May 29 and the Osaka Prefectural Institute of
Public Health confirmed June 18 the woman had been infected with a
strain of the H1N1 virus containing a genetic mutation making it
resistant to Tamiflu. The patient recovered after being given the
drug Relenza.
2. In a July 2 press conference, representatives of the Osaka
Prefectural Government explained the lag between detecting the
Tamiflu resistant strain and reporting it to MHLW on July 1 was due
to further tests needed to re-confirm the initial conclusion.
However, three Institute employees had submitted a paper on the
findings to the U.S. medical journal "Emerging Infectious Diseases"
June 24. Japanese media criticized the Institute as giving priority
to academic reports and not releasing information to the domestic
public.
ZUMWALT